Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 05 2019
Historique:
received: 22 11 2018
accepted: 01 05 2019
entrez: 16 5 2019
pubmed: 16 5 2019
medline: 21 10 2020
Statut: epublish

Résumé

Thoracic diseases in patients with systemic lupus erythematosus (SLE), especially interstitial pneumonia (SLE-IP), are rare and have been poorly studied. The aims of this multicentre study were to evaluate SLE-IP and elucidate its clinical characteristics and prognosis. Fifty-five patients with SLE-IP who had attended the respiratory departments of participating hospitals were retrospectively evaluated in this multicentre study. Clinical information, high-resolution computed tomography (HRCT), and surgical lung biopsy/autopsy specimens were analysed by respiratory physicians, pulmonary radiologists, and pulmonary pathologists. IP patterns on HRCT and lung specimens were classified based on the international classification statement/guideline for idiopathic interstitial pneumonias. The most frequent form of SLE-IP at diagnosis was chronic IP (63.6%), followed by subacute (20.0%), and acute IP (12.7%). Radiologically, the most common HRCT pattern was "Unclassifiable" (54%). Histologically, "Unclassifiable" was the most frequently found (41.7%) among 12 patients with histologically proven IP. Interestingly, accompanying airway diseases were present in nine of these patients (75%). In multivariate analysis, current smoking (hazard ratio [HR] 6.105, p = 0.027), thrombocytopenia (HR 7.676, p = 0.010), anti-double-strand DNA titre (HR 0.956, p = 0.027), and nonspecific interstitial pneumonia (NSIP) + organizing pneumonia (OP) pattern on HRCT (vs. NSIP, HR 0.089, p = 0.023) were significant prognostic factors. In conclusion, chronic IP was the most frequent form of IP in patients with SLE-IP, and "Unclassifiable" was the commonest pattern radiologically and histologically.

Identifiants

pubmed: 31089189
doi: 10.1038/s41598-019-43782-7
pii: 10.1038/s41598-019-43782-7
pmc: PMC6517420
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

7355

Références

Chest. 2009 Nov;136(5):1397-1405
pubmed: 19892679
Chest. 2006 Jul;130(1):22-9
pubmed: 16840378
Presse Med. 2011 Jan;40(1 Pt 2):e19-29
pubmed: 21194884
J Indian Med Assoc. 2012 Feb;110(2):109-11
pubmed: 23029844
Rheumatology (Oxford). 2012 Mar;51(3):491-8
pubmed: 22109798
Am J Respir Crit Care Med. 2002 Jan 15;165(2):277-304
pubmed: 11790668
Arthritis Care Res (Hoboken). 2017 Jul;69(7):997-1003
pubmed: 27696791
Arthritis Care Res (Hoboken). 2014 Apr;66(4):608-16
pubmed: 24106157
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
J Rheumatol. 2002 Feb;29(2):288-91
pubmed: 11838846
Lupus. 2017 Jun;26(7):698-706
pubmed: 27799439
Ann Rheum Dis. 2016 Sep;75(9):1615-21
pubmed: 26458737
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48
pubmed: 24032382
Am J Med. 1981 Nov;71(5):791-8
pubmed: 7304651
Thorax. 2000 Feb;55(2):159-66
pubmed: 10639536
Semin Respir Crit Care Med. 2007 Aug;28(4):389-97
pubmed: 17764057
Sarcoidosis Vasc Diffuse Lung Dis. 2003 Oct;20(3):235-41
pubmed: 14620168
Eur Respir J. 2011 Jun;37(6):1411-7
pubmed: 20884744
Arthritis Rheum. 1992 Jun;35(6):630-40
pubmed: 1599520
Semin Arthritis Rheum. 2018 Oct;48(2):198-204
pubmed: 29550111
Am J Respir Crit Care Med. 2016 Aug 1;194(3):265-75
pubmed: 27299520
Lancet. 2012 Aug 18;380(9842):689-98
pubmed: 22901890
Ann Rheum Dis. 2014 Jan;73(1):183-90
pubmed: 23313811
Lupus. 2001;10(2):93-6
pubmed: 11237132
Lupus Sci Med. 2017 Mar 17;4(1):e000176
pubmed: 28409015
Lupus. 2017 Nov;26(13):1368-1377
pubmed: 28420071
Am J Respir Crit Care Med. 2015 Jul 15;192(2):e3-19
pubmed: 26177183

Auteurs

Noriyuki Enomoto (N)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan. norieno@hama-med.ac.jp.
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan. norieno@hama-med.ac.jp.

Ryoko Egashira (R)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Department of Radiology, Faculty of Medicine, Saga University, Saga, Japan.

Kazuhiro Tabata (K)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Department of Pathology, Nagasaki University Hospital, Nagasaki, Japan.

Mikiko Hashisako (M)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Department of Pathology, Nagasaki University Hospital, Nagasaki, Japan.
Division of Diagnostic Pathology, Kyushu University Hospital, Fukuoka, Japan.

Masashi Kitani (M)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Department of Pathology, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.

Yuko Waseda (Y)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

Tamotsu Ishizuka (T)

Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

Satoshi Watanabe (S)

Department of Respiratory Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

Kazuo Kasahara (K)

Department of Respiratory Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

Shinyu Izumi (S)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Department of Respiratory Medicine, National Centre for Global Health and Medicine, Tokyo, Japan.

Akira Shiraki (A)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Department of Respiratory Medicine, Ogaki Municipal Hospital, Gifu, Japan.

Atsushi Miyamoto (A)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Department of Respiratory Medicine, Respiratory Centre, Toranomon Hospital, Tokyo, Japan.

Kazuma Kishi (K)

Department of Respiratory Medicine, Respiratory Centre, Toranomon Hospital, Tokyo, Japan.

Tomoo Kishaba (T)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Department of Respiratory Medicine, Okinawa Chubu Hospital, Okinawa, Japan.

Chikatosi Sugimoto (C)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Clinical Research Centre, National Hospital Organization Kinki-Chuo Chest Medical Centre, Osaka, Japan.

Yoshikazu Inoue (Y)

Clinical Research Centre, National Hospital Organization Kinki-Chuo Chest Medical Centre, Osaka, Japan.

Kensuke Kataoka (K)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Department of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, Japan.

Yasuhiro Kondoh (Y)

Department of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, Japan.

Yutaka Tsuchiya (Y)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Allergy and Respiratory Medicine, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Tomohisa Baba (T)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Centre, Yokohama, Japan.

Hiroaki Sugiura (H)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Department of Diagnostic Radiology, Keio University School of Medicine, Tokyo, Japan.

Tomonori Tanaka (T)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Department of Pathology, Faculty of Medicine, Kindai University, Osaka, Japan.

Hiromitsu Sumikawa (H)

Diffuse Lung Disease Study Group for Young Generations, Nagasaki, Japan.
Department of Diagnostic Radiology, Sakai City Medical Centre, Osaka, Japan.

Takafumi Suda (T)

Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH